Small cell carcinoma of the esophagus

B. Jereczek-Fossa, M. Airoldi, S. Gribaudo, M. G. Ruo Redda, G. Valente, R. Orecchia

Research output: Contribution to journalArticle

Abstract

Small cell carcinoma of the esophagus (SCEC) is a rare tumor with its particular biologic features, distinct from squamous and glandular carcinoma of esophagus. Although initial symptoms can be similar (with metastatic dissemination and paraneoplastic syndromes at presentation more frequent in SCEC), differences in age and sex distribution, tumor location, radiological and endoscopic findings, clinical course and prognosis have been observed between SCEC and other esophageal malignancies. SCEC should be considered a systemic disease, and by analogy to bronchogenic small cell carcinoma, multi- modality approach including chemotherapy is recommended. In patients with limited disease, irradiation or surgery should be offered after induction chemotherapy to manage local disease. However, optimal treatment schedule has not yet been defined. In the future, registration of all SCEC cases and careful analysis of prognostic factors in the larger multi-institutional series could contribute to further progress in treatment outcome.

Original languageEnglish
Pages (from-to)7-11
Number of pages5
JournalNeoplasma
Volume46
Issue number1
Publication statusPublished - 1999

Fingerprint

Small Cell Carcinoma
Esophagus
Paraneoplastic Syndromes
Neoplasms
Sex Distribution
Induction Chemotherapy
Age Distribution
Squamous Cell Carcinoma
Appointments and Schedules
Drug Therapy

Keywords

  • Chemotherapy
  • Prognosis
  • Radiotherapy
  • Small cell esophageal cancer
  • Surgery

ASJC Scopus subject areas

  • Cancer Research

Cite this

Jereczek-Fossa, B., Airoldi, M., Gribaudo, S., Ruo Redda, M. G., Valente, G., & Orecchia, R. (1999). Small cell carcinoma of the esophagus. Neoplasma, 46(1), 7-11.

Small cell carcinoma of the esophagus. / Jereczek-Fossa, B.; Airoldi, M.; Gribaudo, S.; Ruo Redda, M. G.; Valente, G.; Orecchia, R.

In: Neoplasma, Vol. 46, No. 1, 1999, p. 7-11.

Research output: Contribution to journalArticle

Jereczek-Fossa, B, Airoldi, M, Gribaudo, S, Ruo Redda, MG, Valente, G & Orecchia, R 1999, 'Small cell carcinoma of the esophagus', Neoplasma, vol. 46, no. 1, pp. 7-11.
Jereczek-Fossa B, Airoldi M, Gribaudo S, Ruo Redda MG, Valente G, Orecchia R. Small cell carcinoma of the esophagus. Neoplasma. 1999;46(1):7-11.
Jereczek-Fossa, B. ; Airoldi, M. ; Gribaudo, S. ; Ruo Redda, M. G. ; Valente, G. ; Orecchia, R. / Small cell carcinoma of the esophagus. In: Neoplasma. 1999 ; Vol. 46, No. 1. pp. 7-11.
@article{5080b0cb86714f1c8f362d7b29007e14,
title = "Small cell carcinoma of the esophagus",
abstract = "Small cell carcinoma of the esophagus (SCEC) is a rare tumor with its particular biologic features, distinct from squamous and glandular carcinoma of esophagus. Although initial symptoms can be similar (with metastatic dissemination and paraneoplastic syndromes at presentation more frequent in SCEC), differences in age and sex distribution, tumor location, radiological and endoscopic findings, clinical course and prognosis have been observed between SCEC and other esophageal malignancies. SCEC should be considered a systemic disease, and by analogy to bronchogenic small cell carcinoma, multi- modality approach including chemotherapy is recommended. In patients with limited disease, irradiation or surgery should be offered after induction chemotherapy to manage local disease. However, optimal treatment schedule has not yet been defined. In the future, registration of all SCEC cases and careful analysis of prognostic factors in the larger multi-institutional series could contribute to further progress in treatment outcome.",
keywords = "Chemotherapy, Prognosis, Radiotherapy, Small cell esophageal cancer, Surgery",
author = "B. Jereczek-Fossa and M. Airoldi and S. Gribaudo and {Ruo Redda}, {M. G.} and G. Valente and R. Orecchia",
year = "1999",
language = "English",
volume = "46",
pages = "7--11",
journal = "Neoplasma",
issn = "0028-2685",
publisher = "Vydavatel'stvo Slovenkej Akademie Vied/Veda Publishing House of the Slovak Academy of Sciences",
number = "1",

}

TY - JOUR

T1 - Small cell carcinoma of the esophagus

AU - Jereczek-Fossa, B.

AU - Airoldi, M.

AU - Gribaudo, S.

AU - Ruo Redda, M. G.

AU - Valente, G.

AU - Orecchia, R.

PY - 1999

Y1 - 1999

N2 - Small cell carcinoma of the esophagus (SCEC) is a rare tumor with its particular biologic features, distinct from squamous and glandular carcinoma of esophagus. Although initial symptoms can be similar (with metastatic dissemination and paraneoplastic syndromes at presentation more frequent in SCEC), differences in age and sex distribution, tumor location, radiological and endoscopic findings, clinical course and prognosis have been observed between SCEC and other esophageal malignancies. SCEC should be considered a systemic disease, and by analogy to bronchogenic small cell carcinoma, multi- modality approach including chemotherapy is recommended. In patients with limited disease, irradiation or surgery should be offered after induction chemotherapy to manage local disease. However, optimal treatment schedule has not yet been defined. In the future, registration of all SCEC cases and careful analysis of prognostic factors in the larger multi-institutional series could contribute to further progress in treatment outcome.

AB - Small cell carcinoma of the esophagus (SCEC) is a rare tumor with its particular biologic features, distinct from squamous and glandular carcinoma of esophagus. Although initial symptoms can be similar (with metastatic dissemination and paraneoplastic syndromes at presentation more frequent in SCEC), differences in age and sex distribution, tumor location, radiological and endoscopic findings, clinical course and prognosis have been observed between SCEC and other esophageal malignancies. SCEC should be considered a systemic disease, and by analogy to bronchogenic small cell carcinoma, multi- modality approach including chemotherapy is recommended. In patients with limited disease, irradiation or surgery should be offered after induction chemotherapy to manage local disease. However, optimal treatment schedule has not yet been defined. In the future, registration of all SCEC cases and careful analysis of prognostic factors in the larger multi-institutional series could contribute to further progress in treatment outcome.

KW - Chemotherapy

KW - Prognosis

KW - Radiotherapy

KW - Small cell esophageal cancer

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=0032920276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032920276&partnerID=8YFLogxK

M3 - Article

C2 - 10355527

AN - SCOPUS:0032920276

VL - 46

SP - 7

EP - 11

JO - Neoplasma

JF - Neoplasma

SN - 0028-2685

IS - 1

ER -